Erasca, Inc. (ERAS) Form 10-Q Quarterly Reports
Erasca, Inc. (ERAS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ERAS
CIK: 1761918
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerMelody Stutzman
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-16 | 2026-10-15 | 8-K | 0001193125-26-423433 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001628280-26-065966 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001628280-26-062070 | View SEC Doc Filr Page |
| 8-K | 2026-08-24 | 2026-08-24 | 8-K | 0001193125-26-361895 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001628280-26-057296 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352396 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | 4 | 0001193125-26-346924 | View SEC Doc Filr Page |
| 3 | 2026-08-12 | 2026-08-10 | 3 | 0001193125-26-346920 | View SEC Doc Filr Page |
| S-8 | 2026-08-11 | — | S-8 | 0001193125-26-344845 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-344611 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-344584 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-342669 | View SEC Doc Filr Page |
| 144 | 2026-07-21 | — | 144 Filing | 0001628280-26-048993 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-13 | 8-K | 0001193125-26-303357 | View SEC Doc Filr Page |
| 424B5 | 2026-07-14 | — | 424B5 | 0001193125-26-303352 | View SEC Doc Filr Page |
| 424B5 | 2026-07-13 | — | 424B5 | 0001193125-26-302148 | View SEC Doc Filr Page |
| 8-K | 2026-07-13 | 2026-07-13 | 8-K | 0001193125-26-302045 | View SEC Doc Filr Page |
| S-3ASR | 2026-07-13 | — | S-3ASR | 0001193125-26-302035 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-06-26 | 8-K | 0001193125-26-290881 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | 4 | 0001193125-26-288910 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | 4 | 0001193125-26-288908 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | 4 | 0001193125-26-288906 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | 4 | 0001193125-26-288905 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | 4 | 0001193125-26-288903 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | 4 | 0001193125-26-288902 | View SEC Doc Filr Page |